Cocaine and Myocardial Infarctions

Advanced Studies in Medicine

Volumn 3, Issue 8, 2003, Pages 448-454+470

  Lange, Richard A ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; PHENTOLAMINE;

ATHEROSCLEROSIS; CIGARETTE SMOKING; COCAINE DEPENDENCE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY RISK; DRUG ABUSE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; RECOGNITION; REVIEW; THORAX PAIN;

EID: 0242540576     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Hahn IH, Hoffman RS. Cocaine use and acute myocardial infarction. Emerg Med Clin North Am. 2001;19:493-510.
2. Coleman DL, Ross TF, Naughton JL. Myocardial ischemia and infarction related to recreational cocaine use. West J Med. 1982;136:444-446.
3. OAS 2001. Office of Applied Studies. SAMHSA, Drug Abuse Warning Network. 2001 National Household Survey on Drug Abuse (NHSDA). Volume I, 2001 Summary of Findings: Cocaine.
4. National Institute on Drug Abuse. Crack and cocaine. NIDA InfoFacts. 2003. Available at: www.nida.nih.gov/Infofax/cocaine.html.
5. Qureshi AI, Suri MF, Guterman LR, Hopkins IN. Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey. Circulation. 2001;103:502-506.
6. Monitoring the Future. National Results on Adolescent Drug Use: Overview of Key Findings, 2002. Bethesda, Md:National Institute on Drug Abuse; 2003:45.
7. Schwartz RH, Lewis DC, Hoffmann NG, Kyriazi N. Cocaine and marijuana use by medical students before and during medical school. Arch Intern Med. 1990;150:883-886.
8. Baldwin DC Jr, Hughes PH, Conard SE, Storr CL, Sheehan DV. Substance use among senior medical students. A survey of 23 medical schools. JAMA. 1991;265(16):2074-2078.
9. SAMHSA, 2000. Office of Applied Studies. Year-End 1999 Emergency Department Data from the Drug Abuse Warning Network # Series. DHHS Publication (SMA) 00-3462.
10. Drug Abuse Warning Network. Major drugs of abuse in ED visits, 2001 update. DAWN Rep. October 2002:1.
11. OAS/DAWN 2002. Office of Applied Studies, SAMHSA, Drug Abuse Warning Network. ED Trends from DAWN. (09/2002 update): Tables 3.8 and 5.8.0.
12. Hollander, JE. The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333:1267-1272
13. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med. 1990;88:325-331.
14. MacDonald DI. Cocaine leads emergency department drug visits. JAMA. 1987;258:2029.
15. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001.345:351-358.
16. Jeffcoat AR, Perez-Reyes M, Hill JM, Sadler BM, Cook CE. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos. 1989;17:153-159.
17. Om A, Ellahham S, Ornato JP, et al. Medical complications of cocaine: possible relationship to low plasma cholinesterase enzyme. Am Heart J. 1993;125:1114-1117.
18. Kerns W, Garvey L, Owens J. Cocaine-induced wide complex dysrhythmia. J Emerg Med. 1997;15:321-329.
19. Kloner RA, Hale S, Alker K, Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation. 1992;85:407-419
20. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med. 1994;1:330-339.
21. Hollander JE, Todd KH, Green G, et al. Chest pain associated with cocaine: an assessment of prevalence in suburban and urban emergency departments. Ann Emerg Med. 1995;26:671-676.
22. Gitter MJ, Goldsmith SR, Dunbar DN, Sharkey SW. Cocaine and chest pain: clinical features and outcome of patients hospitalized to rule out myocardial infarction. Ann Intern Med. 1991;115:277-282.
23. Amin M, Gabelman G, Karpel J, Bultrick P. Acute myocardial infarction and chest pain syndromes after cocaine use. Am J Cardiol. 1990;66:1434-1437.
24. Pitts WR, Lange RA, Cigarroa JE, Hillis LD. Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management. Prog Cardiovasc Dis. 1997;40:65-76.
25. Mittleman MA, Mintzer D, Maclure M, et al. Triggering of myocardial infarction by cocaine. Circulation. 1999;99:2737-2741
26. Hollander JE, Hoffman RS, Burstein JL, Shih RD, Thode HC. Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med. 1995;155:1081-1086.
27. Weber JE, Shofer FS, Larkin GL, et al. Validation of a brief observation period for patients with cocaine-associated chest pain. N Engl J Med. 2003;348:510-517.
28. Hollander JE, Vignona L, Burstein J. Predictors of underlying coronary artery disease in cocaine associated myocardial infarction: a meta-analysis of case reports. Vet Hum Toxicol. 1997;39:276-280.
29. Smith HW, Liberman HA, Brody SL, et al. Acute myocardial infarction temporally related to cocaine use. Clinical, angiographic, and pathophysiologic observations. Ann Intern Med. 1987;107:13-18.
30. Minor RL Jr, Scott BD, Brown DD, Winniford MD. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med. 1991;115:797-806.
31. Lange RA, Cigarroa RG, Yancy CW, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989;321:1557-1562.
32. Boehrer JD, Moliterno DJ, Willard JE, et al. Hemodynamic effects of intranasal cocaine in humans. J Am Coll Cardiol. 1992;20:90-93.
33. Flores ED, Lange RA, Cigarroa RG, Hillis LD. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol. 1990;16:74-79.
34. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990;112:897-903.
35. American Heart Association Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: advanced cardiovascular life support: section 1: introduction to ACLS 2000: overview of recommended changes in ACLS from the guidelines 2000 conference. Part 8: advanced challenges in resuscitation: section 2: toxicology in ECC. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation. 2000;102(suppl):186-189, 1223-1228.
36. Boehrer JD, Moliterno DJ, Willard JE, Hillis LD, Lange RA. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med. 1993;94:608-610.
37. Moliterno DJ, Lange RA, Gerard RD, et al. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med. 1994;96:492-496.
38. Siegel AJ, Mendelson JH, Sholar MB, et al. Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen. Am J Cardiol. 2002;89:1133-1135
39. Brogan WC, Lange RA, Glamann DB, Hillis LD. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med. 1992;116:556-561.
40. Nicod P, Rehr R, Winniford MD, et al. Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease. J Am Coll Cardiol. 1984;4:964-971.
41. Klein LW, Ambrose J, Pichard A, et al. Acute coronary hemodynamic response to cigarette smoking in patients with coronary artery disease. J Am Coll Cardiol. 1984;3:879-886.
42. Moliterno DJ, Willard JE, Lange RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med. 1994;330:454-459.
43. Brogan WC, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 1991;18:581-586.
44. Baumann BM, Perrone J, Hornig SE, Shofer FS, Hollander JE. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med. 2000;7:878-885.
45. Negus BH, Willard JE, Hillis LD, et al. Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil. Am J Cardiol. 1994;73:510-513.
46. Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. N Engl J Med. 1992;327:361.
47. Hollander JE, Burstein JL, Hoffman RS, Shih RD, Wilson LD. Cocaine-associated myocardial infarction: clinical safety of thrombolytic therapy. Chest. 1995;107:1237-1241.
48. Hoffman RS, Hollander JE. Thrombolytic therapy and cocaine inducedmyocardial infarction. Am J Emerg Med. 1996;14:693-695.